Advances in the Surgical Treatment of Urologic Cancer
A special issue of Current Oncology (ISSN 1718-7729).
Deadline for manuscript submissions: closed (15 November 2023) | Viewed by 245
Special Issue Editor
Interests: bladder cancer; urachal cancer; urology; endourology; urologic oncology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
In urological oncology, the four most prevalent tumors develop in the prostate, bladder, kidney and testicles. In the bladder, we can find non-muscle invasive tumors and muscle invasive tumors, requiring totally a different approach and type of surgery. In the kidney, both renal cell carcinomas and urothelial carcinomas can be found in the collecting system. Apart from (topical) chemo- and immunotherapy, surgery still plays an important role in the treatment and cure of patients with urological tumors. Surgery may range from endoscopic surgery for non-invasive bladder and pyelum tumors, to minimal invasive radical surgery by laparoscopy (e.q. smaller kidney tumors) or robotic surgery (e.g. invasive bladder tumors, prostate cancer and partial nephrectomies) to open radical surgery (e.g. in bladder cancer, residual masses after chemotherapy for testicular cancer, and larger renal tumors).
In this Special Issue, several endoscopic, minimally invasive and open radical types of operation in cases of patients with urological tumors will be presented and discussed.
You may choose our Joint Special Issue in Cancers.
Dr. Laura S. Mertens
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Oncology is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- bladder cancer
- prostate cancer
- testicular cancer
- kidney cancer
- surgery
- robotic
- laparoscopy
- transurethral resection
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
